The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis

Cell Host & Microbe
Agnieszka D TruaxJenny P-Y Ting

Abstract

In addition to high-fat diet (HFD) and inactivity, inflammation and microbiota composition contribute to obesity. Inhibitory immune receptors, such as NLRP12, dampen inflammation and are important for resolving inflammation, but their role in obesity is unknown. We show that obesity in humans correlates with reduced expression of adipose tissue NLRP12. Similarly, Nlrp12-/- mice show increased weight gain, adipose deposition, blood glucose, NF-κB/MAPK activation, and M1-macrophage polarization. Additionally, NLRP12 is required to mitigate HFD-induced inflammasome activation. Co-housing with wild-type animals, antibiotic treatment, or germ-free condition was sufficient to restrain inflammation, obesity, and insulin tolerance in Nlrp12-/- mice, implicating the microbiota. HFD-fed Nlrp12-/- mice display dysbiosis marked by increased obesity-associated Erysipelotrichaceae, but reduced Lachnospiraceae family and the associated enzymes required for short-chain fatty acid (SCFA) synthesis. Lachnospiraceae or SCFA administration attenuates obesity, inflammation, and dysbiosis. These findings reveal that Nlrp12 reduces HFD-induced obesity by maintaining beneficial microbiota.

Citations

Dec 12, 2018·Natural Product Reports·Xue Ming Wu, Ren Xiang Tan
May 1, 2019·Current HIV/AIDS Reports·Ivan Vujkovic-Cvijin, Ma Somsouk
Jul 3, 2019·Cellular Microbiology·Nathaniel WinsorStephen E Girardin
May 1, 2019·Nature Reviews. Immunology·Karen V SwansonJenny P-Y Ting
Jan 14, 2020·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Simon GhalyPrue H Hart
Feb 11, 2020·Gut Microbes·Sara L ColemanBrent E Palmer
May 21, 2020·Cell Research·Danping ZhengEran Elinav
Jul 14, 2020·Immunological Reviews·Timur LiwinskiEran Elinav
Sep 18, 2020·The Journal of Experimental Medicine·Hao GuoJenny P Y Ting
Jun 11, 2020·Annual Review of Nutrition·Samuel Philip NobsEran Elinav
May 28, 2020·Expert Review of Neurotherapeutics·Urdhva RavalGiulio M Pasinetti
Oct 23, 2019·Signal Transduction and Targeted Therapy·Ziying ZhangYongguang Tao
Jan 17, 2020·International Journal of Molecular Sciences·Shahanshah Khan, Hasan Zaki
Mar 3, 2019·Journal of Neuroinflammation·Qianquan MaRong-Fu Wang
Feb 20, 2020·International Journal of Molecular Sciences·Fionán DonohoeDonal J Brennan
Dec 2, 2020·Biology·Andrea BalliniRoberto Arrigoni
Sep 24, 2020·International Journal for Parasitology·Shin Ae KangHak Sun Yu
Nov 13, 2020·Frontiers in Immunology·Torsten P M ScheithauerHilde Herrema
Feb 3, 2021·International Journal of Molecular Sciences·Ioannis KienesThomas A Kufer
Feb 12, 2021·Journal of Applied Microbiology·Ebenezeri Erasto NgowiDong-Dong Wu
Oct 11, 2020·Signal Transduction and Targeted Therapy·Ziying ZhangYongguang Tao
Apr 4, 2021·International Journal of Molecular Sciences·Snehaa V Seal, Jonathan D Turner
Mar 19, 2021·Journal of Applied Microbiology·Yifan WuLanwei Zhang
May 14, 2021·Best Practice & Research. Clinical Endocrinology & Metabolism·Rebeca Liébana-GarcíaYolanda Sanz
Jun 6, 2021·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Maria Angela GuzzardiAnnamaria Colao
Jun 24, 2021·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Jason A BubierGeorge M Weinstock
Jul 2, 2021·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chyi-Song HsiehNadia N Hansel
Jul 18, 2021·European Journal of Pharmacology·Xin YeXinjian Wan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.